CSF amyloid betaBiomarker1 paperHumans1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 3Oct 2026: 03Alzheimer's & DementiaHumans·13 SepHippocampal mediation in the lipid-Alzheimer's disease pathway: A high-dimensional mediation analysis stratified by APOE and sexMechanismsNeuroscienceHumans·4 SepLower serum serotonin is associated with greater cardiovascular risk burden and poorer cognitive outcomes in mild cognitive impairment and amyloid-positive participantsMild cognitive impairmentAlzheimer's & DementiaHuman trial·3 SepBridging language markers and pathology: correlations between digital speech measures and surrogate CSF biomarkers in Alzheimer's diseaseAlzheimer's disease
Alzheimer's & DementiaHumans·13 SepHippocampal mediation in the lipid-Alzheimer's disease pathway: A high-dimensional mediation analysis stratified by APOE and sexMechanisms
NeuroscienceHumans·4 SepLower serum serotonin is associated with greater cardiovascular risk burden and poorer cognitive outcomes in mild cognitive impairment and amyloid-positive participantsMild cognitive impairment
Alzheimer's & DementiaHuman trial·3 SepBridging language markers and pathology: correlations between digital speech measures and surrogate CSF biomarkers in Alzheimer's diseaseAlzheimer's disease